Europe Noninvasive Ventilation Masks Market Trends by 2030
市场洞察和分析师观点:
无创通气 (NIV) 是氧气输送(通气)支持)通过面罩,消除了对气管内呼吸道的需要。 NIV 通过减少呼吸功和改善气体交换,提供与传统机械通气相当的生理益处。该干预措施被认为是治疗慢性阻塞性肺病(COPD)呼吸衰竭、心源性肺水肿和其他呼吸系统疾病的有效方法,且无上呼吸道损伤、呼吸机相关性肺炎、呼吸肌无力和鼻窦炎等并发症。因此,呼吸系统疾病患病率的上升极大地影响了欧洲无创通气面罩市场的增长。
增长动力和挑战:
欧洲慢性阻塞性肺疾病 (COPD) 和呼吸系统疾病的患病率不断上升推动了欧洲无创通气面罩市场的增长。慢性阻塞性肺病是最重要的公共卫生问题之一。根据国家医学图书馆 2022 年发表的题为《德国慢性阻塞性肺病患者家庭远程监测计划的有效性》的文章,德国报告了约 600 万慢性阻塞性肺病病例。一篇题为“体弱的瑞士人对慢性阻塞性肺病了解多少?”的文章指出。 2021 年发表的报告显示,瑞士约有 40 万人受到慢性阻塞性肺病 (COPD) 的影响。
患有潜在慢性阻塞性肺病 (COPD) 且病情恶化、高碳酸血症性呼吸困难或呼吸衰竭的患者最有可能通过无创通气 (NIV) 获得成功治疗。 NIV有效缓解呼吸肌压力,增加潮气量,降低呼吸频率,减少膈式呼吸做功,从而改善供氧,减少高碳酸血症,改善呼吸困难。 COPD 是 NIV 的理想选择,因为治疗可快速逆转,并且可以提供额外的支持。
NIV 可以降低 COPD 患者的气管插管率、住院时间、机械通气并发症和死亡率。最近的临床实践指南推荐 NIV 作为治疗 COPD 急性呼吸衰竭 (ARF) 的一线通气支持。 NIV 面罩越来越多地用于治疗患有慢性阻塞性肺病 (COPD) 和呼吸衰竭的患者。
无创通气 (NIV) 有助于减少因慢性阻塞性肺病 (COPD) 恶化并伴有呼吸衰竭的患者的插管和死亡率。面罩的类型可能会影响成功率。对于病情严重且患有 ARF 的患者,建议使用全面罩而不是鼻罩。因此,欧洲慢性阻塞性肺病和其他呼吸系统疾病的患病率不断上升,推动了欧洲无创通气面罩市场的增长。此外,
未来趋势:
NIV 面罩产品的技术进步预计将在未来几年带来欧洲无创通气面罩市场的新趋势。 NIV 是患有呼吸或睡眠呼吸障碍患者的标准护理。技术进步使得能够开发出更新的自动 NIV 调节模式,适用于受复杂呼吸异常影响的患者,而传统气道正压治疗可能难以有效管理这些异常。当通风需求波动时,这些模式可以实现稳定的通风。 CPAP 对非插管成人或儿童患者施加持续气道正压通气。它可用于需要短期机械辅助的自主呼吸患者。治疗的有效性与鼻罩或全面罩在患者面部的正确密封有关。
接口的选择是 NIV 成功的最关键步骤之一。企业在研发口罩时,非常注重形状、材质、舒适度、减少泄漏等。然而,新产品的不断发展增加了接口的可用性和满足不同要求的能力。对于在急性和慢性家庭环境中每天需要数小时 NIV 的患者来说,交替使用其他接口仍然是一个很好的策略,以降低皮肤损伤的风险并提高患者的耐受性。瑞思迈提供了一款智能 NIV 面罩,可以帮助根据患者独特且不断变化的需求定制治疗方案。增加开发技术先进产品的合作和研发投资,旨在刺激未来几年欧洲无创通气面罩市场的增长。
细分分析:
欧洲无创通气面罩通过考虑以下细分市场进行了市场分析:接口、应用、用途、材料、尺寸、产品类型和最终用户。
根据接口,市场分为面罩和配件。口罩部分包括鼻罩、面罩、鼻枕罩、口腔罩和全面罩/头盔。面罩进一步细分为二氧化碳排放面罩和非排放面罩。 NIV 面罩的配件包括弯头和替换弯头、软管、管子、皮肤屏障、鼻下/鼻垫以及头带/替换装备。口罩部分包括鼻罩、面罩、鼻枕罩、口腔罩和全罩/头盔。鼻罩呈三角形结构,戴在鼻子周围。连接到框架上的四点式头带通常用于将鼻罩固定到位。使用鼻罩会刺激鼻罩所在的鼻梁。鼻枕是密封鼻孔底部的缓冲垫,并通过环绕后脑勺的弹力带帮助固定。鼻枕安装在鼻孔处以提供气压。
全面罩覆盖整个面部,包括鼻子和嘴唇。有些有前额稳定器,可以帮助活跃的睡眠者获得更好的缓冲密封。头带通常有四个接触点,以保持稳定性并更容易调整。一些制造商最近对全面罩进行了改造,使其位于使用者的鼻子下方。这些设计显着限制了面部接触,并减少了某些全面罩使用者所经历的幽闭恐惧症。
全罩式面罩通过四点式头套固定到位,并密封在整个脸部周围的宽椭圆形中以封闭鼻子、嘴和眼睛。在接受睡眠呼吸暂停治疗时,一些患者会出现眼角漏气的情况。如果发生这种情况,其他面罩将无法正常工作,应考虑使用全面罩。面部问题可能会导致患者无法佩戴鼻罩或全面罩。全面罩与全面罩一样,可以均衡压力,使空气处理保持一致,但它也覆盖整个面部以及任何空气可能逸出的区域,例如眼睛。
口腔面罩使用椭圆形面罩垫仅将气流输送至口腔。这些面罩是全面罩的绝佳替代品。它的工作原理是在嘴周围形成密封,并通过面罩内的两个入口输送空气。这种方法非常适合夜间通过嘴呼吸的人
欧洲无创通气面罩市场报告的范围包括对英国、德国、法国、奥地利、瑞士和其他地区市场表现的评估欧洲。
欧洲无创通气面罩市场份额,按产品类型 - 2022 年和 2030 年
区域分析:
从地理上看,欧洲无创通气面罩市场分为英国、德国、法国、奥地利、瑞士和欧洲其他国家。德国是市场的最大贡献者。无创通气广泛应用于各种病因的急性呼吸衰竭 (ARF) 的急性护理环境中。根据国家医学图书馆2022年发表的题为《德国慢性阻塞性肺病患者家庭远程监测计划的有效性》的文章,德国记录了约600万例慢性阻塞性肺病病例。 NIV有效缓解呼吸肌压力,增加潮气量,降低呼吸频率,减少膈式呼吸做功,从而改善供氧,减少高碳酸血症,改善呼吸困难。 NIV 面罩是慢性阻塞性肺病的理想选择,因为治疗可快速逆转,并且可以提供额外的支持。因此,德国慢性阻塞性肺病患病率的上升推动了德国无创通气口罩市场的增长。
医疗器械的报销政策也决定了德国欧洲无创通气口罩市场的增长。重症监护病房 (ICU) 使用的 NIV 口罩治疗费用在该国得到报销,在家庭病例中,患者必须自掏腰包支付费用。德国住院期间有利的报销方案推动了德国无创通气面罩市场的增长。
竞争格局和主要公司:
Fisher & Paykel Healthcare Ltd、Armstrong Medical Ltd、Intersurgical Ltd、Hamilton Medical、ResMed、Koninklijke Philips NV、Ambu AS、Dragerwerk AG & Co KGaA、DEAS SRL 和 SunMed Group Holdings LLC 是欧洲无创通气面罩市场报告中介绍的知名企业。此外,研究期间还对其他几家参与者进行了研究和分析,以全面了解市场及其生态系统。这些公司专注于地域扩张和新产品发布,以满足全球消费者不断增长的需求,并增加其专业产品组合的产品范围。他们的存在使他们能够服务于庞大的客户群,从而促进欧洲无创通气面罩市场的扩张。
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The increasing prevalence of chronic obstructive pulmonary diseases and inclination towards home healthcare propel the market growth. However, the side effects of NIV masks hamper the market's growth. Technological advancement will bring new Europe noninvasive ventilation mask market trends in the coming years.
Non-invasive ventilation (NIV) is the delivery of oxygen (ventilation support) through a face mask, eliminating the need for an endotracheal airway. NIV provides comparable physiological benefits to conventional mechanical ventilation by reducing breathing work and improving gas exchange. The intervention is recognized as an effective treatment for respiratory failure in chronic obstructive pulmonary disease, cardiogenic pulmonary edema, and other respiratory conditions without complications, such as upper airway trauma, ventilator-associated pneumonia, respiratory muscle weakness, and sinusitis.
Based on interfaces, the Europe non-invasive ventilation masks market is bifurcated into masks and accessories. The masks segment consists of nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmets. Accessories of NIV masks include elbows and replacement elbows, hoses, tubes, skin barriers, under/over the nose cushions, and head strap/replacement gears. In 2022, the masks segment held a larger market share and is expected to record a higher CAGR from 2022 to 2030.
Based on application, the Europe non-invasive ventilation masks market is segmented into respiratory dysfunction, chronic obstructive pulmonary disease, pneumonia, and others. In 2022, the respiratory dysfunction segment held Europe's largest noninvasive ventilation masks market share. Moreover, the same segment is expected to record the highest CAGR during 2022–2030.
Based on usage, the Europe non-invasive ventilation masks market is bifurcated into pediatrics and adults. In 2022, the adult segment held a larger European noninvasive ventilation masks market share. Moreover, the same segment is expected to record a higher CAGR during 2022–2030.
Based on size, the Europe non-invasive ventilation masks market is segmented into large, medium, and small. In 2022, the medium segment held a larger market share and is expected to record a higher CAGR during 2022–2030. Large and medium-size masks are used to treat adults. Growing pollution and smoking is responsible for increasing cases of respiratory diseases and lung-related diseases. Thus, the rising prevalence of respiratory diseases such as COPD, ARF, asthma, and hospital-acquired pneumonia in adults fuels the demand for large and medium-size masks. Furthermore, in patients affected by severe acute asthma, adding NIV to conventional treatment improves lung function and alleviates the exacerbation faster. In patients suffering from COPD, neuromuscular diseases, and obesity hypoventilation syndrome, noninvasive positive pressure ventilation (NIPPV) results in lower mortality, intubations, hospital admissions, and better quality of life. Also, the increase in cases of neurodegenerative diseases and sleep apnea in adults drives the market growth for the segment. Increasing use of masks in treating respiratory diseases fuels the Europe non-invasive ventilation masks market growth for the large and medium segments.
Based on material, the Europe non-invasive ventilation masks market is further segmented into silicon, gel, and others. In 2022, the silicon segment held Europe's largest noninvasive ventilation masks market share. Moreover, the same segment is expected to record the highest CAGR during 2022–2030.
Based on product type, the Europe non-invasive ventilation masks market is bifurcated into single-use and reusable. In 2022, the reusable segment held a larger Europe noninvasive ventilation masks market share. Moreover, the same segment is expected to record a higher CAGR during 2022–2030.
The Europe noninvasive ventilation masks market, by end user, is segmented into hospitals, critical and acute care settings, ambulatory surgical centers, and others. In 2022, the hospital segment held the largest share of the market and is expected to record the highest CAGR from 2022 to 2030.
The Europe noninvasive ventilation masks market majorly consists of players such Fisher & Paykel Healthcare Ltd, Armstrong Medical Ltd, Intersurgical Ltd, Hamilton Medical, ResMed, Koninklijke Philips NV, Ambu AS, Dragerwerk AG & Co KGaA, DEAS S.R.L, and SunMed Group Holdings LLC.
The List of Companies - Europe Noninvasive Ventilation Masks Market
- Fisher & Paykel Healthcare Ltd
- Armstrong Medical Ltd
- Intersurgical Ltd
- Hamilton Medical
- ResMed
- Koninklijke Philips NV
- Ambu AS
- Dragerwerk AG & Co KGaA
- DEAS S.R.L
- SunMed Group Holdings LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.